PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients
F. Kleiburg*, L.F. de Geus-Oei, S.A.C. Luelmo, R. Spijkerman, J.J. Goeman, F.A.J. Toonen, F. Smit, T. van der Hulle, L. Heijmen
Research output: Contribution to journal › Article › Scientific › peer-review
20Downloads
(Pure)
Fingerprint
Dive into the research topics of 'PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients'. Together they form a unique fingerprint.